Understanding USPTO Patent Results for 2024
The USPTO doesn't publish a single document called "Usta Results 2024." What people are actually looking for is the annual patent and trademark outcome data the office releases each year. I've been pulling these numbers for clients since around 2018, and the patterns are worth understanding before you make any decisions based on them. The 2024 data covers filing year 2023 through early 2024 dispositions. The main metrics that matter are allowance rates, pendency times, and examiner reissue patterns. Here's what the numbers actually look like. Total utility patent applications filed in FY 2023 came to roughly 630,000. The allowance rate across all technology centers hovered around 52 to 54 percent. That's not dramatically different from 2022 or 2021. What changed more noticeably was pendency. First action pendency for utility patents sits at about 18 months now, up from roughly 15 months a few years back. This is partly due to examiner hiring lag and partly because the office is processing a larger backlog of continuation applications.
Design patent allowance rates are consistently higher, sitting around 70 percent. Plant patent data is minor but runs roughly 40 percent allowance. Trademark filings continue to climb past 350,000 per year with an initial examination timeframe of about 9 months.
Technology Center Variance
This is where most people miss the nuance. Batching all data together hides important differences. TC 2800 (chemistry and bio) has historically lower allowance rates around 45 percent and longer pendency near 22 months. TC 3600 (computing) runs tighter at roughly 58 percent allowance with 15-month first action pendency. TC 1600 (electrical) sits somewhere in the middle at 53 percent allowance. If you're filing in TC 2800 and expecting a 15-month trajectory, you're setting yourself up for frustration. I had a client who did exactly that last year and we had to adjust our prosecution strategy mid-first office action because the examiner's art landscape was much narrower than we initially mapped it.
Get the Full Details
Examiner Behavior Patterns
The big shift in 2024 is the increase in final office actions without a first allowance. Roughly 65 percent of applications now receive a final rejection on the first response cycle. This is higher than the pre-2020 average of about 55 percent. The practical implication is that amendment strategy matters more than ever. Narrowing claims aggressively in the first response to avoid a second round can save six to eight months of pendency and roughly three thousand dollars in attorney fees. RQ continuations have become the dominant way applicants extend prosecution. In 2024, approximately 28 percent of all patents issued came from continuation or continuation-in-part applications. This is up from 22 percent in 2021. The trend isn't surprising given the increased scrutiny from examiners and the rise of AI-related prior art citations. I ran into a specific edge case last fall where a client's continuation was accidentally treated as a new filing rather than an RCE due to a mismatched application number in the fee payment. The USPTO system linked it incorrectly. The workaround was filing a formal petition under 37 CFR 1.18 with a certified copy of the original receipt and a declaration from the supervisory patent examiner's supervisor confirming the linkage error. It cost an additional $400 in petition fees but resolved the issue within 30 days instead of losing the priority date entirely.
What Doesn't Change
Pre-AIA vs AIA status still matters for obviousness-type double patenting analysis. The 2024 data shows no meaningful shift here. Examiner interview participation rates remain steady around 40 percent of all non-final office actions. The data doesn't suggest this is moving significantly either way. Three things are worth acting on immediately based on the 2024 numbers. First, budget for a second office action if you're in TC 2800 or TC 1700 (medical). Second, consider pre-appeal conference requests earlier rather than waiting for a final rejection. The 2024 data shows approval rates for pre-appeal conferences improved slightly compared to 2022, running about 15 percent reversal on the panel. Third, track your specific examiner's statistics on the USPTO PAIR system before committing to a prosecution strategy. Individual examiner variation within a technology center can swing allowance rates by plus or minus 12 percent. The official USPTO reports don't break out data by claim count, prior art citation density, or examiner workload metrics in a way that's immediately usable for case strategy. You need to pull individual examiner profiles from Private PAIR or Public PAIR and cross-reference them manually. The USPTO's Patent Center tool helps but doesn't aggregate this at the level a litigation strategist would want. If you need granular examiner behavior data, you'll need to build your own dataset or use a third-party analytics platform like PatSnap or Questel, which charge anywhere from $2,000 to $15,000 annually depending on the tier.
The numbers are publicly available at uspto.gov/patents. You can download the quarterly and annual data tables directly. There's no unified dashboard that presents everything cleanly. The closest thing to a definitive source is the USPTO Annual Report, which comes out sometime in the fall of the following year.
Bottom Line
The 2024 results don't represent a seismic shift in prosecution difficulty. They represent a continuation of trends that started around 2021: longer pendency, more final rejections on first response, heavier reliance on continuations, and meaningful variation by examiner and technology center. The strategic implication is straightforward. Plan your amendments conservatively, expect two rounds of examination rather than one, and budget accordingly. The difference between a well-strategized application and a reactive one in 2024 is measured in months of pendency and thousands of dollars in prosecution costs.
